These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9972854)

  • 1. Possible involvement of a sigma receptor subtype in the neck dystonia in rats.
    Nakazawa M; Kobayashi T; Matsuno K; Mita S
    Pharmacol Biochem Behav; 1999 Jan; 62(1):123-6. PubMed ID: 9972854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
    Okumura K; Ujike H; Akiyama K; Kuroda S
    J Neural Transm (Vienna); 1996; 103(10):1153-61. PubMed ID: 9013402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological identification of SM-21, the novel sigma(2) antagonist.
    Ghelardini C; Galeotti N; Bartolini A
    Pharmacol Biochem Behav; 2000 Nov; 67(3):659-62. PubMed ID: 11164098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes.
    Bouchard P; Quirion R
    Neuroscience; 1997 Jan; 76(2):467-77. PubMed ID: 9015331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain.
    Kobayashi T; Matsuno K; Murai M; Mita S
    Neurochem Res; 1997 Sep; 22(9):1105-9. PubMed ID: 9251100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.
    Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S
    Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test.
    Matsuno K; Kobayashi T; Tanaka MK; Mita S
    Eur J Pharmacol; 1996 Oct; 312(3):267-71. PubMed ID: 8894608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma binding parameters in developing rats predict behavioral efficacy of a sigma ligand.
    Hemstreet MK; Matsumoto RR; Bowen WD; Walker JM
    Brain Res; 1993 Nov; 627(2):291-8. PubMed ID: 8298974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma1 receptor subtype does not interact with stereotyped behaviors in rats.
    Kobayashi T; Matsuno K; Mita S
    Pharmacol Biochem Behav; 1998 Dec; 61(4):381-4. PubMed ID: 9802832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats.
    Senda T; Matsuno K; Okamoto K; Kobayashi T; Nakata K; Mita S
    Eur J Pharmacol; 1996 Nov; 315(1):1-10. PubMed ID: 8960858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.
    Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment.
    Faherty CJ; Harkin AJ; Leonard BE
    Eur J Pharmacol; 1998 Apr; 346(1):15-21. PubMed ID: 9617747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B; Debonnel G
    Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain.
    Kobayashi T; Matsuno K; Nakata K; Mita S
    J Pharmacol Exp Ther; 1996 Oct; 279(1):106-13. PubMed ID: 8858982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures.
    Nakazawa M; Matsuno K; Mita S
    Neurochem Int; 1998 Apr; 32(4):337-43. PubMed ID: 9596556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.
    Xu R; Lord SA; Peterson RM; Fergason-Cantrell EA; Lever JR; Lever SZ
    Bioorg Med Chem; 2015 Jan; 23(1):222-30. PubMed ID: 25468036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug specificity of pharmacological dystonia.
    Matsumoto RR; Hemstreet MK; Lai NL; Thurkauf A; De Costa BR; Rice KC; Hellewell SB; Bowen WD; Walker JM
    Pharmacol Biochem Behav; 1990 May; 36(1):151-5. PubMed ID: 2161543
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.